<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01203670</url>
  </required_header>
  <id_info>
    <org_study_id>PHYTHEA-e437-950</org_study_id>
    <nct_id>NCT01203670</nct_id>
  </id_info>
  <brief_title>Renal and Digestive Tolerance of a Food Supplement, Phytalgic, in Elderly Volunteers - A Multicentric Open Trial</brief_title>
  <official_title>Renal and Digestive Tolerance of a Food Supplement, Phytalgic, in Elderly Volunteers - A Multicentric Open Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phythea</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phythea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate renal and digestive tolerance of a food supplement,
      phytalgic, on elderly volunteers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <completion_date type="Actual">December 2009</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal tolerance by Glomerular filtration rate (GFR) determination; Digestive tolerance by Aspartate Amino transferase (ASAT), Alanine Amino Transferase (ALAT), gamma Glutamyl Transpeptidase (gamma GT), lipase and amylase determination</measure>
    <time_frame>168 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life determined by Western Ontario and McMaster universities (WOMAC)Visual Analogue Scale(VAS)</measure>
    <time_frame>168 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Renal Tolerance</condition>
  <condition>Digestive Tolerance</condition>
  <arm_group>
    <arm_group_label>Soft capsules of Phytalgic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phytalgic is a food supplement. Its galenic form is soft capsule.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Phytalgic</intervention_name>
    <description>Volunteers have to take three soft capsules per day, one in the morning and two in the evening.</description>
    <arm_group_label>Soft capsules of Phytalgic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  70 years old minimum

          -  Satisfying general health judged by principal investigator

          -  Pain and /or stifness associated with arthritis

          -  Regular used of analgesics and/or non-steroidal anti-inflammatory drugs (NSAIDs)

          -  Digestive tolerance biomarkers

               1. ASAT : Men &lt; 150 UI/L - Women &lt; 100 UI/L

               2. ALAT : Men &lt; 180 UI/l - Women &lt; 130 UI:l

               3. Gamma GT Men &lt; 180 UI/l - Gamma GT Women &lt; 100 UI/l

               4. Amylase &lt; 250 UI/l

               5. Lipase &lt; 750 UI/l

          -  Renal tolerance biomarker: Glomerular filtration rate (GFR)superior or equal to 60 mL
             /min / 1.73m3 - calculated with the &quot;Modification of the Diet in Renal Diseases&quot;
             formula

        Exclusion Criteria:

          -  Inflammatory arthritis

          -  Allergy to any constituents of the study drug

          -  Types 2 diabetes

          -  Not legally fit to participate

          -  Any treatment able to modify determined biological parameters
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>87 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain JACQUET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Département de pharmacologie Clinique - Université Victor Segalen Bordeaux 2 - Centre Hospitalo-Universitaire de Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Département de Pharmacologie Clinique - Université Victor Segalen Bordeaux 2 - CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2010</study_first_submitted>
  <study_first_submitted_qc>September 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2010</study_first_posted>
  <last_update_submitted>September 21, 2010</last_update_submitted>
  <last_update_submitted_qc>September 21, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>Pr. Nicholas MOORE</name_title>
    <organization>Département de pharmacologie Clinique - Université Victor Segalen Bordeaux 2 - Centre hospitalier universitaire de Bordeaux</organization>
  </responsible_party>
  <keyword>Glomerular filtration rate (GFR)</keyword>
  <keyword>Aspartate Amino Transferase (ASAT)</keyword>
  <keyword>Alanine Amino transferase (ALAT)</keyword>
  <keyword>gamma Glutamyl transpeptidase (gamma GT)</keyword>
  <keyword>Lipase</keyword>
  <keyword>Amylase</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

